Study Stopped
not enough participants
Comparison of Anesthesia Type in Patients Undergoing Transabdominal Cervico Isthmic Cerclage (TCIC)
Comparison of General Anesthesia and Combined Spinal-epidural Anesthesia on Postoperative Outcomes in Patients Undergoing Transabdominal Cervico Isthmic Cerclage (TCIC)
1 other identifier
interventional
20
1 country
1
Brief Summary
The investigator aimed to compare the effect of anesthesia on overall postoperative outcomes including post-operative pain score and the fetal well-being (heart rate) in patients undergoing transabdominal cervico isthmic cerclage(TCIC). The investigator divided the patients into two groups. The first group was the patients who undergo general anesthesia with postoperative wound patient-controlled analgesia device(PCA) and the second group was the patients who undergo combined spinal-epidural anesthesia(CSE) with postoperative epidural catheter PCA device for pain control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2018
CompletedStudy Start
First participant enrolled
August 1, 2018
CompletedFirst Posted
Study publicly available on registry
August 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedSeptember 4, 2020
January 1, 2020
1.8 years
August 1, 2018
September 2, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Pain score at 24hours after the end of the operation
Numerical Rating Score(0-10), 0:no pain, 5:moderate pain, 10:worst pain
Assessed by directly asking to the patient, from date of randomization up to postoperative day 3.
Secondary Outcomes (1)
Fetal viability on postoperative day 5
Assessed by ultrasonography, upto postoperative day 5.
Study Arms (2)
Spinal anesthesia group
EXPERIMENTALSpinal anesthesia is used for operation with epidural patient-controlled device for pain control. Bupivacaine Hcl 0.5% Inj. 9-10mg is injected into intrathecal space for anesthesia. 0.2% ropivacaine is used for postoperative pain control with continuous infusion into epidural space.
General anesthesia group
ACTIVE COMPARATORGeneral anesthesia is used for operation with wound patient-controlled device for pain control. propofol (10milligram/ML) 1.5-2 mg/ml is used as bolus intravascular injection for induction of anesthesia. 0.5% ropivacaine is used for postoperative pain control with continous infusion through wound catheter.
Interventions
The patients undergo surgery under spinal anesthesia and a catheter would be inserted into epidural space during the procedure. 0.5% bupivacaine is injected into intrathecal space for spinal anesthesia. For pain control, 0.2% ropivacaine is continuously infused into epidural space postoperatively.
The patients undergo surgery under general anesthesia and a catheter would be inserted to abdominal incision site at the end of the operation. Propofol is used for induction of general anesthesia, and sevoflurane is used for maintenance of anesthesia. At the end of the operation, the surgeon inserts wound catheter in the surgical site and connects wound patient-controlled analgesia device filled with 0.5% ropivacaine.
Eligibility Criteria
You may qualify if:
- Patients who undergo TCIC for IIOC and agree to participate in this study.
You may not qualify if:
- Hepatic failure
- Chronic kidney disease(\>stage III)
- Hypersensitivity, allergic response and/or resistance to drugs used in this study(ex. pethidine, ropivacaine)
- Spinal anesthesia is not possible
- Refuse to participate in the study
- Cannot understand the agreement
- Body weight is under 50 kg or over 100 kg
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kangnam sungshim hospital
Seoul, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Eunmi Choi, MD.PhD
Kangnam sungshim hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2018
First Posted
August 17, 2018
Study Start
August 1, 2018
Primary Completion
June 1, 2020
Study Completion
June 1, 2020
Last Updated
September 4, 2020
Record last verified: 2020-01